BACKGROUND: Fusobacterium nucleatum (Fn) has been identified as a causative factor in the progression of colon cancer. This study aims to integrate bulk RNA-seq with single-cell RNA-seq (scRNA-seq) to elucidate the molecular mechanisms by which Fn facilitates colon cancer progression. METHODS: The scRNA-seq data from tumor tissues of Fn intervention were analyzed to screen cells with significant proportion changes. Differentially expressed genes of cells with different proportions were extracted and intersected with those identified in the bulk RNA-seq analysis. Three machine learning algorithms were employed to identify characteristic genes. Clinical tissue samples and external datasets, along with in vitro co-culture experiments, were utilized to validate these findings. RESULTS: Following Fn intervention, there was an observed increase in the fibroblast iso-cellular ratio and interaction levels. Utilizing machine learning algorithms, we identified five key genes. The differential expression of Serpine2 was validated using clinical samples and external datasets. Furthermore, patients with metastatic colon cancer exhibited significantly higher Serpine2 expression compared to those without metastasis. Fn was found to significantly enhance the expression of Serpine2 in fibroblasts and to promote the proliferation and migration capabilities of tumor cells. CONCLUSION: This study elucidates the role of Fn in promoting colon cancer progression through the enhancement of fibro-macrophage-epithelial cell interactions. Furthermore, Serpine2 has been identified as a potential molecular marker associated with Fn-mediated colon cancer progression and metastasis. These findings contribute novel insights that may inform the development of therapeutic strategies for colon cancer.
Enhancing fibroblast-epithelial cell communications: Serpine2 as a key molecule in Fusobacterium nucleatum-promoted colon cancer.
增强成纤维细胞-上皮细胞通讯:Serpine2 是具核梭杆菌促进结肠癌的关键分子
阅读:5
作者:Li Xueke, Luo Simin, Jiang Yifang, Ma Qiong, You Fengming, Kuang Qixuan, Fu Xi, Zheng Chuan
| 期刊: | Frontiers in Immunology | 影响因子: | 5.900 |
| 时间: | 2025 | 起止号: | 2025 Jun 26; 16:1563922 |
| doi: | 10.3389/fimmu.2025.1563922 | 研究方向: | 细胞生物学 |
| 疾病类型: | 肠癌 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
